Literature DB >> 9740188

Leg ulceration in the sickle cell patient.

M Cackovic1, C Chung, L L Bolton, M D Kerstein.   

Abstract

BACKGROUND: The purpose of this study was to determine cost of care for leg ulcers in sickle cell patients and suggest an improved modality in ulcer care. STUDY
DESIGN: We performed a retrospective study of a group of sickle cell disease patients with leg ulcers.
RESULTS: Eighteen patients with a leg ulcer (duration: mean, 53.7 months), sickle cell disease, and a mean of 20.7 years of age had various modalities of treatment with the only consistency in healing being a commercial moist-wound dressing.
CONCLUSIONS: There is no consistency in the treatment of the sickle cell patient with a leg ulcer. Treatment with a moist dressing had the best results.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9740188     DOI: 10.1016/s1072-7515(98)00196-3

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  4 in total

Review 1.  [Genetic causes of impaired wound healing. Rare differential diagnosis of the non-healing wound].

Authors:  K Elsharkawi-Welt; J Hepp; K Scharffetter-Kochanek
Journal:  Hautarzt       Date:  2008-11       Impact factor: 0.751

Review 2.  Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine.

Authors:  Eden Avishai; Kristina Yeghiazaryan; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-03-03       Impact factor: 6.543

3.  Refractory sickle cell leg ulcer: is heparan sulphate a new hope?

Authors:  Shady Hayek; Saad Dibo; Joe Baroud; Amir Ibrahim; Denis Barritault
Journal:  Int Wound J       Date:  2014-02-21       Impact factor: 3.315

Review 4.  A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease.

Authors:  Igor A Altman; Raymond E Kleinfelder; John G Quigley; William J Ennis; Caterina P Minniti
Journal:  Int Wound J       Date:  2015-11-04       Impact factor: 3.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.